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Abstract Raised intraocular pressure (IOP) is the most
important risk factor for developing glaucoma, the second
commonest cause of blindness globally. Understanding
associations with IOP and variations in IOP between
countries may teach us about mechanisms underlying glau-
coma. We examined cross-sectional associations with IOP in
43,500 European adults from 12 cohort studies belonging to
the European Eye Epidemiology (E3) consortium. Each
study conducted multivariable linear regression with IOP as
the outcome variable and results were pooled using random
effects meta-analysis. The association of standardized study
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IOP with latitude was tested using meta-regression. Higher
IOP was observed in men (0.18 mmHg; 95 % CI 0.06, 0.31;
P = 0.004) and with higher body mass index (0.21 mmHg
per 5 kg/m2; 95 % CI 0.14, 0.28; P\ 0.001), shorter height
(-0.17 mmHg per 10 cm; 95 % CI –0.25, -0.08;
P\ 0.001), higher systolic blood pressure (0.17 mmHg per
10 mmHg; 95 % CI 0.12, 0.22; P\ 0.001) and more myo-
pic refraction (0.06 mmHg per Dioptre; 95 % CI 0.03, 0.09;
P\ 0.001). An inverted U-shaped trend was observed
between age and IOP, with IOP increasing up to the age of 60
and decreasing in participants older than 70 years. We found
no significant association between standardized IOP and
study location latitude (P = 0.76). Novel findings of our
study include the association of lower IOP in taller people
and an inverted-U shaped association of IOP with age. We
found no evidence of significant variation in IOP across
Europe. Despite the limited range of latitude amongst
included studies, this finding is in favour of collaborative
pooling of data from studies examining environmental and
genetic determinants of IOP in Europeans.
Keywords Intraocular pressure  Epidemiology  Body
mass index  Refractive errors  Blood pressure  Glaucoma
Introduction
Glaucoma is the second commonest cause of blindness
globally following cataract, accounting for 8 % of world
blindness [1]. Raised intraocular pressure (IOP) is an
important risk factor for the incidence [2] and progression
[3] of the commonest form of glaucoma, primary open-
angle glaucoma (POAG). Understanding which systemic
and ocular parameters are associated with IOP gives us
insight into the pathophysiological mechanisms underlying
IOP and may ultimately lead to new targets or treatment
methods for POAG. Examining geographic trends in dis-
ease may also shed light on disease risk and aetiology. For
example, differential rates of coronary heart disease mor-
tality across Europe gave impetus to research demonstrat-
ing a beneficial effect of a Mediterranean diet [4].
Several European population studies have reported IOP
data [5–9]. However, individual studies suffer from limited
sample size and results may only apply to the geographical
region examined. We therefore conducted a study of IOP
data from 12 population-based studies across Europe,
maximising power to detect small associations and
increasing generalisability to European populations. We
also aimed to compare IOP between studies, in particular
comparing IOP in studies from Southern Europe with IOP
in studies from more northern Europe (including Northern,
Central and Western Europe), potentially reflecting dif-
ferences in lifestyle, such as diet [10], as well as latitude.
Methods
The European Eye Epidemiology (E3) consortium is a
collaborative network of 38 population-based studies
across Europe with the overarching aim of developing and
analysing large pooled datasets to increase understanding
of eye disease and vision loss [11]. Data on IOP were
available from 12 E3 studies from 6 countries (Table 1).
All data from contributing studies were cross-sectional in
nature and if multiple IOP measurements were taken per
participant, these were measured on the same day. Detailed
methods for the studies are given in Supplementary Sec-
tion A. All studies adhered to the tenets of the Declaration
of Helsinki and had local ethical committee approval. All
participants gave written informed consent.
IOP was measured using Goldmann applanation
tonometry (GAT) in 6 studies and non-contact tonometry
(NCT) in 6 studies (Table 1). We defined participant IOP
as the mean of right and left eye values. Participants with
an inter-eye difference in IOP of[6 mmHg were excluded
as this may indicate undiagnosed ocular disease or artefact
(the 6 mmHg cut-off was based on approximately twice the
standard deviation).
Factors to be tested for association with IOP were
decided a priori, based on common measures available in
all studies with IOP data available; these were age, sex,
height, body mass index (BMI), systolic blood pressure
(SBP), refractive error (mean spherical equivalent [SE] of
right and left eyes), and history of cataract surgery.
For initial analyses, we excluded participants with a
history of a glaucoma therapy (laser, surgery or medication)
or intraocular surgery (other than cataract surgery) in either
eye. After examining the association of cataract surgery
with IOP, we further excluded all participants with a history
of cataract surgery, given the strong effect on IOP. Our
main analyses were conducted on phakic patients only.
To examine the associations between IOP and the vari-
ables of interest, we used linear regression. Primary multi-
variable models included all the main variables of interest
(age, sex, height, BMI, SBP and SE; referred to as ‘‘Model
1’’). We also further adjusted for central corneal thickness
(CCT) in the subset of participants with CCT data available
(‘‘Model 2’’). There was no evidence for multicollinearity
among variables included in the multivariable regression
models. For all regression analyses, residuals were plotted
and displayed normality. Regression analyses were con-
ducted for each individual study, and then random-effects
meta-analysis was used to combine the effect estimates. A
random effects approach was decided a priori given the
between study heterogeneity in IOP measurement methods.
We conducted an influential analysis that examined the
contribution of each study to the heterogeneity by
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sequentially omitting one study and reanalysing the pooled
estimate for the remaining studies. We further examined the
association between age and IOP, stratified into age groups
based on initial results. Additionally, to address the poten-
tial bias of participants with the highest IOP being excluded
due to using IOP-lowering therapy, we repeated analyses
including participants on IOP-lowering medication; for
these participants we imputed pre-treatment IOP by divid-
ing measured IOP by 0.7 (‘‘Model 3’’). This approach
assumes an average IOP reduction of 30 % on medical
treatment and has been used successfully in the study of
genetic associations with IOP [12]. For the Coimbra Eye
Study, data on SBP were not available and multivariable
adjusted effect estimates were adjusted for age, sex, height,
BMI and SE only; we therefore conducted sensitivity
analyses of excluding the Coimbra Eye Study from the
meta-analyses. Regression analyses for data from the Twins
UK study included data from both twins in each pair and
therefore used a clustered analysis approach to account for
any correlation between twins. We explored the shapes of
the associations with IOP by plotting random effects meta-
analyzed IOP levels with 95 % confidence intervals by
ordinal categories of the variables.
Comparing raw mean IOP values between studies is
problematic given the different distribution of IOP-associ-
ated parameters across the studies. We therefore calculated
a standardized IOP for each study using multivariable linear
regression, based on fixed covariable parameters; these
parameters were set to values likely to be included within
the range values of values for each study (age 65 years, sex
1.5, SBP 135 mmHg, height 165 cm, BMI 25 kg/m2, SE 0).
To compare IOP in different regions in Europe, we divided
the studies into ‘‘northern’’ and ‘‘southern’’ groups using an
arbitrary latitude cut-point of 50 to derive two similarly
sized groups (i.e. the definitions of ‘‘northern’’ and
‘‘southern’’ are based on dividing the included studies into
two groups rather than being representative of geographic
regions in Europe). We used random-effects meta-analysis
to derive pooled standardized IOP estimates, and these were
compared using the independent samples t test. We exam-
ined the association between standardized IOP and latitude
as a continuous variable using meta-regression. We also
compared standardized IOP in GAT studies with stan-
dardized IOP in NCT studies, and further examined the
association between latitude and standardized IOP stratified
by tonometry method.
Table 2 Meta-analyzed associations with intraocular pressure (IOP)
Unadjusted Model 1 Model 2
Difference in IOP (95 %
CI), mmHg
P value Difference in IOP (95 %
CI), mmHg
P value Difference in IOP (95 %
CI), mmHg
P value
Phakic participants
Age (per decade) 0.06 (-0.03, 0.16) 0.21 -0.05 (-0.16, 0.06) 0.34 0.00 (-0.19, 0.19) 0.97
Female sex 0.00 (-0.13, 0.13) 1.00 -0.18 (-0.31, -0.06) 0.004 -0.04 (-0.20, 0.12) 0.65
BMI (per 5 kg/m2) 0.29 (0.22, 0.35) <0.001 0.21 (0.14, 0.28) <0.001 0.25 (0.18, 0.31) <0.001
Height (per 10 cm) -0.12 (-0.19, -0.04) 0.003 -0.17 (-0.25, -0.08) <0.001 -0.14 (-0.25, -0.04) 0.008
SBP (per 10 mmHg) 0.19 (0.15, 0.23) <0.001 0.17 (0.12, 0.22) <0.001 0.19 (0.13, 0.25) <0.001
Spherical equivalent (per
dioptre)
-0.04 (-0.07, -0.01) 0.007 -0.06 (-0.09, -0.03) <0.001 -0.07 (-0.08, -0.06) <0.001
Phakic and pseudophakic
participants
Cataract surgerya -0.61 (-0.81, -0.41) <0.001 -0.63 (-0.87, -0.40) <0.001 -0.68 (-1.13, -0.23) 0.003
Phakic participants with
CCT data
CCT (per 40 lm)b 0.96 (0.57, 1.35) <0.001 – – 0.97 (0.59, 1.35) <0.001
Results are for all phakic participants (n = 43,500), except for cataract surgery (includes pseudophakic participants in addition)a and CCT (a
subset of phakic participants)b
Unadjusted—results are from univariable regression models
Model 1—results from multivariable regression models adjusted for age, sex, body mass index (BMI), height, systolic blood pressure (SBP) and
spherical equivalent
Model 2—adjusted for central corneal thickness (CCT) in addition to covariables adjusted for in Model 1 (n = 21,332)
a Analyses carried out on data from phakic and pseudophakic participants (n = 46,081 for unadjusted and Model 1; n = 21,332 for Model 2)
b Analyses carried out on data from 21,332 phakic participants with complete data for CCT in addition to other covariables
P values\ 0.05 are in bold
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Stata version 13.1 (StataCorp LP, College Station, TX)
was used for all analyses.
Results
A total of 46,081 participants from 12 population-based
studies were included. The mean age of participants ranged
from 49 to 81 years, and 57 % were women (Table 1).
Mean IOP ranged from 13.6 mmHg in the Rotterdam
Study III to 16.0 mmHg in the EPIC-Norfolk Eye Study
(Table 1).
In total, 2581 participants (5.6 %) had undergone cat-
aract surgery in at least one eye; on average, these partic-
ipants had 0.61 mmHg lower IOP (Table 2). All but four
studies had CCT measurements available (Fig. 1). On
average, IOP was measured 0.96 mmHg higher per 40 lm
thicker CCT (Table 2). For subsequent analyses, we
excluded participants with a history of cataract surgery;
results below refer to a total of 43,500 phakic participants
for primary analyses and 21,332 participants with CCT
data also available for further adjustment.
Table 2 presents crude and adjusted meta-analyzed
associations with IOP. Figure 1 presents the Forest plots
for the meta-analyses adjusted for age, sex, BMI, height,
SBP and SE. Age was not significantly associated with IOP
in these linear analyses. Sex was only associated with IOP
in adjusted analyses; women had 0.18 mmHg lower IOP
(P = 0.004). Both BMI and SBP were positively associ-
ated with IOP in crude and adjusted analyses (all
P\ 0.001). Height was negatively associated with IOP in
crude and adjusted analyses (Model 1 P\ 0.001; Model 2
P = 0.008). A more myopic refraction was associated with
higher IOP (P\ 0.001 for adjusted analyses). The R2 for
IOP in the maximally adjusted multivariable models for
each study ranged from 0.09 in the Rotterdam Study II to
0.27 in the Gutenberg Health Study. An influential analysis
did not identify one study that consistently contributed to
heterogeneity and omitting one study at a time did not
meaningfully change any of the results (Supplementary
Section B).
Figure 2 illustrates the shapes of the associations with
IOP. There were clear linear associations with IOP across
the whole ranges of height, BMI, SBP and SE. There was a
suggestion of an inverted-U shaped association between
age and IOP. To further explore this potential non-linear
relationship, we examined the association between age and
IOP stratified into 3 age categories (Table 3). We found
Fig. 1 Forest plots for associations with intraocular pressure (IOP).
All associations were adjusted for age, sex, body mass index (BMI),
systolic blood pressure (SBP), height and spherical equivalent unless
otherwise indicated. Results are for phakic participants (n = 43,500)
except for cataract surgery (phakic and pseudophakic, n = 46,081)
and CCT (n = 21,332 with complete data). Single asterisk SBP was
not measured or adjusted for in the Coimbra Eye Study. Double
asterisks CCT was not measured in these studies
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evidence for increasing IOP with older age in participants
under 60 years, though this was only statistically signifi-
cant for the crude analysis (P = 0.005). There was con-
sistent evidence for decreasing IOP with older age in
participants 70 years or older (all P\ 0.01). There did not
appear to be a significant relationship between IOP and age
for participants aged 60–69 years in primary analyses. To
further explore whether the reduction of IOP with
increasing age in the oldest participants was due to
exclusion of participants with higher IOP following com-
mencement of IOP-lowering medication, we repeated the
analysis including participants on IOP-lowering medication
and imputing their pre-treatment IOP, and observed similar
associations (Table 3, Model 3).
Figure 3 presents the standardized IOP for each country
in a Forest plot, stratified by latitude. Standardized IOP
varied between 13.7 mmHg in Rotterdam Study III to
16.3 mmHg in the Montrachet Study. The meta-analyzed
standardized IOP for all European studies was 14.8 mmHg
(95 % CI 14.3, 15.3), and there was no significant differ-
ence between northern studies (meta-analyzed IOP
14.80 mmHg) and southern studies (meta-analyzed IOP
14.75 mmHg), as shown in Fig. 3 (P = 0.95). We also
carried out a meta-regression to examine whether stan-
dardized IOP was associated with latitude considered as a
continuous variable (Fig. 4); we found no significant
association (P = 0.76). As shown in Supplementary Fig-
ure 1, the standardized IOP for all studies that used NCT
(15.2 mmHg; 95 % CI 14.2, 16.2) was higher than the
standardized IOP for all studies that used GAT
(14.5 mmHg; 95 % CI 14.1, 15.0), though the difference
was not statistically significant (P = 0.32). We therefore
also compared northern versus southern standardized IOP
stratified by tonometry method (Supplementary Figure 1);
there were no significant differences for either the GAT
studies (P = 0.56) or the NCT studies (P = 0.83). Further,
we also carried out meta-regressions using latitude as a
continuous variable, stratified by tonometry method (Sup-
plementary Figure 2); there was no significant association
for the GAT studies (P = 0.51) or the NCT studies
(P = 0.85).
Discussion
In this large study examining IOP in over 40,000 partici-
pants from six European countries, we confirmed previ-
ously reported relationships of IOP with SBP, BMI,
refractive error and previous cataract surgery. More novel
findings include a negative association between IOP and
height and an inverted-U-shaped association between IOP
and age. The mean standardized IOP was 14.8 mmHg
across all studies, and we did not find any significant
geographical trends.
While the IOP-lowering effect of cataract extraction in
individuals has been consistently reported in longitudinal
surgical case series [13], it is less clear whether people who
have undergone cataract surgery have lower IOP than
people who have not within a population. The 0.6 mmHg
lower IOP we found in pseudophakic compared to phakic
Fig. 2 Mean intraocular pressure (IOP) and 95 % confidence intervals plotted for ordinal categories of explanatory variables
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participants is significant at a population level, and would
translate into around a 10 % reduction in the 5-year inci-
dence of glaucoma based on data from the Rotterdam
Study [2], all other factors being equal.
There is no consensus on the direction of association
between IOP and age in the literature, with studies
reporting increasing IOP [14–17], decreasing IOP
[5, 8, 18–21] or no association of IOP [22] with older age.
Possible reasons for this inconsistency are differential
associations by population, or a non-monotonic relation-
ship between age and IOP such that different studies of
different aged participants yield different results. An
inverted-U shaped relationship between age and IOP was
suggested by data from the Beijing Eye Study, though these
results were unadjusted and only certain between group
comparisons were statistically significant [23]. We found
strong evidence for an inverted-U shaped relationship, with
IOP increasing linearly with age up to the age of 60 years,
IOP linearly decreasing with age above 70 years, and a
plateau with no significant association between the ages of
60 and 70 years. The decrease in IOP with age in the oldest
age groups was still observed even after including partic-
ipants receiving IOP-lowering medication, reducing the
chance that the association is a result of bias due to par-
ticipants with the highest IOP being excluded in older age
due to commencement of therapy. If we assume that par-
ticipants with higher IOP were more likely to undergo
cataract surgery, it remains a possibility that the decline in
IOP with age in people older than 70 years is due to
exclusion of pseudophakic participants.
The reported association between IOP and sex is also
inconsistent between studies; most studies (not included in
the current meta-analysis) have reported higher IOP in
women [15, 17, 18, 21, 22], though higher IOP in men
[5, 16] or no association between IOP and sex have also
been reported [19]. We found higher IOP in men, but only
in adjusted analyses, and not in the subset with CCT
available for further adjustment. This inconsistency raises
the possibility of a chance finding. While higher IOP in
men is in agreement with a higher risk of POAG in men
[24], it is possible that a higher prevalence of angle-closure
in women [25] also contributes to a sex-differential for
IOP; iridocorneal drainage angle width may be an impor-
tant determinant of IOP, even among healthy participants.
We found a significant decrease in IOP with greater
height, even after adjustment for possible confounders.
This is a relatively novel finding; while a negative crude
association of height with IOP was reported in the Tanjong
Pagar Study, this was not significant after adjustment for
confounders [14]. Our finding is in agreement with the
lower prevalence of POAG reported in taller participants of
the Beijing Eye Study [26]. The mechanism underlying
lower IOP in taller people is not clear, but may be related toT
a
b
le
3
A
ss
o
ci
at
io
n
s
b
et
w
ee
n
ag
e
an
d
in
tr
ao
cu
la
r
p
re
ss
u
re
(I
O
P
),
st
ra
ti
fi
ed
b
y
ag
e-
g
ro
u
p
A
g
e
g
ro
u
p
(y
ea
rs
)
U
n
ad
ju
st
ed
M
o
d
el
1
M
o
d
el
2
M
o
d
el
3
D
if
fe
re
n
ce
in
IO
P
p
er
d
ec
ad
e
o
ld
er
(9
5
%
C
I)
,
m
m
H
g
P
v
al
u
e
D
if
fe
re
n
ce
in
IO
P
p
er
d
ec
ad
e
o
ld
er
(9
5
%
C
I)
,
m
m
H
g
P
v
al
u
e
D
if
fe
re
n
ce
in
IO
P
p
er
d
ec
ad
e
o
ld
er
(9
5
%
C
I)
,
m
m
H
g
P
v
al
u
e
D
if
fe
re
n
ce
in
IO
P
p
er
d
ec
ad
e
o
ld
er
(9
5
%
C
I)
,
m
m
H
g
P
v
al
u
e
\
6
0
0
.2
7
(0
.0
8
,
0
.4
6
)
0
.0
0
5
0
.1
3
(-
0
.0
7
,
0
.3
3
)
0
.2
2
0
.0
0
(-
0
.0
7
,
0
.0
7
)
0
.9
1
0
.2
8
(0
.1
7
,
0
.3
9
)
<
0
.0
0
1
6
0
–
6
9
0
.1
2
(-
0
.0
5
,
0
.2
9
)
0
.1
6
0
.0
1
(-
0
.1
7
,
0
.1
9
)
0
.9
1
0
.2
4
(-
0
.2
7
,
0
.7
5
)
0
.3
5
0
.2
3
(0
.0
1
,
0
.4
5
)
0
.0
3
8
C
7
0
-
0
.2
1
(-
0
.3
5
,
-
0
.0
7
)
0
.0
0
3
-
0
.2
8
(-
0
.4
4
,
-
0
.1
2
)
0
.0
0
1
-
0
.5
9
(-
1
.0
4
,
-
0
.1
4
)
0
.0
1
0
-
0
.2
5
(-
0
.4
1
,
-
0
.0
9
)
0
.0
0
2
M
o
d
el
1
—
re
su
lt
s
fr
o
m
m
u
lt
iv
ar
ia
b
le
re
g
re
ss
io
n
m
o
d
el
s
ad
ju
st
ed
fo
r
se
x
,
b
o
d
y
m
as
s
in
d
ex
(B
M
I)
,
h
ei
g
h
t,
sy
st
o
li
c
b
lo
o
d
p
re
ss
u
re
(S
B
P
)
an
d
sp
h
er
ic
al
eq
u
iv
al
en
t
(n
=
4
3
,5
0
0
)
M
o
d
el
2
—
ad
ju
st
ed
fo
r
ce
n
tr
al
co
rn
ea
l
th
ic
k
n
es
s
in
ad
d
it
io
n
to
co
v
ar
ia
b
le
s
ad
ju
st
ed
fo
r
in
M
o
d
el
1
(n
=
2
1
,3
3
2
)
M
o
d
el
3
—
in
cl
u
d
in
g
p
ar
ti
ci
p
an
ts
ta
k
in
g
IO
P
-l
o
w
er
in
g
m
ed
ic
at
io
n
(w
it
h
im
p
u
te
d
p
re
-t
re
at
m
en
t
IO
P
),
ad
ju
st
ed
fo
r
se
x
,
B
M
I,
h
ei
g
h
t,
S
B
P
an
d
sp
h
er
ic
al
eq
u
iv
al
en
t
(n
=
4
4
,1
4
3
)
P
v
al
u
es
\
0
.0
5
ar
e
in
b
o
ld
Associations with intraocular pressure across Europe: The European Eye Epidemiology (E3)… 1107
123
the distance between the eye and the heart. We hypothesise
that ciliary body perfusion and resultant aqueous produc-
tion is lower the higher the eye is above the heart, and that
this distance is larger in taller people. This is in agreement
with the findings that IOP is lower in the sitting position
compared with supine [27], and that IOP is lower in the
higher eye of study participants in the lateral decubitus
position [28].
The significant associations we found between IOP and
BMI, SBP and spherical equivalent are consistent with the
literature. The majority of published studies have reported
higher IOP with higher BMI [15, 17–20, 22, 29, 30], higher
SBP [14, 15, 17, 18, 20, 22, 31, 32], and more myopic
refraction [23, 30] or longer axial length [20]. We have
further examined the shapes of these relationships with IOP
and found linear associations for BMI, SBP and spherical
equivalent (Fig. 2). The linear relationship between BMI
and IOP across the whole range of BMI is of particular
interest. It has been suggested that the relationship between
BMI and IOP is due to artefactual high IOP readings in
people of high BMI due to an induced Valsalva manoeuvre
at slit lamp examination [33]. However, our findings of
higher IOP with BMI even at the lower end of the BMI
range argue against the Valsalva hypothesis. For example,
it would not be expected that a participant of normal BMI
would have a greater degree of Valsalva manoeuvre
induced at slit lamp examination than an underweight
participant. Furthermore, the association between BMI and
IOP was seen in studies using NCT, which may be less
prone to inducing a Valsalva manoeuvre. The mechanism
by which higher BMI increases IOP remains unclear, but
may be related to metabolic syndrome in general [34]. A
meta-analysis of epidemiological data suggests an
increased risk of glaucoma in myopic people [35]. Higher
IOP in myopic eyes may be the mechanism by which
glaucoma risk is increased. What remains unclear is why
IOP is higher in myopic eyes. A possible hypothesis is that
abnormal elongation of the eye is associated with a degree
of malformation of drainage angle microstructure.
We did not find striking variability of IOP levels
between the European countries participating in this study,
and did not find any variation in IOP with latitude. This
may be in part due to relative genetic and cultural
Fig. 3 Forest plot of
standardized intraocular
pressure (IOP), stratified by
latitude. Pooled associations for
northern studies, southern
studies, and overall were
derived using random effects
meta-analysis. The right column
presents standardized IOP in
mmHg (95 % confidence
interval)
Fig. 4 Meta-regression for the association between latitude and
standardized intraocular pressure (IOP)
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homogeneity among the predominantly Caucasian popu-
lations in this study, and in contrast to the significant dif-
ference seen in IOP of Japanese people compared with
Europeans [36]. It is also likely that between study
heterogeneity in IOP ascertainment limits meaningful
comparisons of absolute IOP values, and reduces statistical
power to identify small differences. One such difference in
study methods is GAT versus NCT, and while we did
repeat analyses stratified by tonometry method, the number
of studies within each group was small and limited power
for finding any differences. Furthermore, our studies did
not represent a large range in latitude and were not entirely
representative of Northern (e.g. lacking studies from
Scandinavia) and Southern Europe. Future work combining
studies in a larger global consortium may be better able to
detect an association between IOP and latitude. Despite our
negative findings, and the limitations of this approach,
comparing IOP levels between countries remains an
important method of potentially identifying new environ-
mental associations with IOP.
The major strengths of our study are the large pooled
sample size allowing identification of small effect associ-
ations, and the increased generalisability derived from
demonstrating associations across multiple populations.
Many epidemiological studies are limited by the possibility
of chance findings or that findings are only relevant in the
reported population. We have reported associations that
were present when considering data from six different
countries together, and could also examine the results from
each study alone in relation to the pooled findings using the
Forest plots. We can therefore be more certain that our
results were not due to chance, and are likely applicable to
many Caucasian populations within and outside Europe.
There are also limitations to our study. Meta-analysis of
summary data is a useful approach, but post hoc analysis is
limited by the pre-specified analysis compared with pool-
ing of raw data. However, the feasibility of sharing raw
participant data between studies is limited by local study
ethics arrangements. Another issue with meta-analysis is
between study heterogeneity, which can limit the validity
of statistically combining results. The degree of hetero-
geneity in the meta-analyses we conducted was variable,
with I2 statistics ranging from 0 to 98 %. While random
effects meta-analysis assumes a distribution of the true
effect due to between study heterogeneity, it may not
always be appropriate to statistically combine results from
studies that used vastly different methods. For this reason,
we also ran analyses for the major associations (Table 2;
Fig. 1) stratified by tonometry method (GAT studies and
NCT studies separately); this yielded very similar results
(data not shown). While absolute IOP values may vary
between GAT and NCT, the direction and strength of
association of measured IOP with systemic factors did not
appear to differ significantly. Another limitation is that
Eastern European populations were not represented in our
study sample. The cross-sectional nature of our data may
limit causal inference for the associations detected.
In summary, novel findings from this large pan-Euro-
pean study included an inverted-U shaped association of
IOP with age, and lower IOP in taller participants. We did
not find significant variation in IOP across Europe. Our
findings have implications for the design of future studies
seeking novel aetiological factors for IOP, such as genetic
association studies; depending on the study age-range,
linear adjustment for age may not be appropriate, and
pooling of data from studies of people of European descent
may be appropriate given the lack of variation in IOP we
have observed across Europe.
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